6.5 C
New York
Thursday, November 26, 2020

The partnership between Novartis and Microsoft seems promising

Must Read

Can robots be more or less racist?

Protests against structural racism in the United States seem to have gone deep. Artificial intelligence (AI) developers have now...

American economist: US Economic future is bleak and the villain is the Fed

Many analysts link the recent record of the Wall Street Dow Jones index with optimism for a vaccine against...

Scientists claim an unknown ability of alligators

The reptile's tail can reach up to 18% of its entire body length after losing its tail. American scientists have...
Amit Kumar
Amit Kumar is editor-in-chief and founder of Revyuh Media. He has been ensuring journalistic quality and shaping the future of Revyuh.com - in terms of content, text, personnel and strategy. He also develops herself further, likes to learn new things and, as a trained mediator, considers communication and freedom to be essential in editorial cooperation. After studying and training at the Indian Institute of Journalism & Mass Communication He accompanied an ambitious Internet portal into the Afterlife and was editor of the Scroll Lib Foundation. After that He did public relations for the MNC's in India. Email: amit.kumar (at) revyuh (dot) com ICE : 00 91 (0) 99580 61723

Novartis is in the process of digitally upgrading. Since Bertrand Bodson joined the newly created post of Chief Digital Officer in January 2018, a number of projects have been launched that will take the pharmaceutical company into the new era of analyzing large amounts of data. Up to now, the necessary capacity expansion has mainly taken place in-house, or they have teamed up with small start-up companies, for example to test new instruments in the field of artificial intelligence.

Three-country laboratory

Now, Novartis is embarking on a bigger leap and starting a cooperation with IT group Microsoft. The goal of the five-year collaboration is to bundle the artificial intelligence capabilities of the two companies, thereby triggering an innovation boost in the pharmaceutical business. The plan is to create an AI Innovation Lab with locations on the Novartis campus in Basel, the company’s Global Service Center in Dublin, and the Microsoft Research Lab in the UK. Bodson did not comment on the staffing levels of this new facility and the size of the planned investments. He emphasized, however, that both companies contributed funds to the project.

On the one hand, the increased technological potential should serve to accelerate the development of new drugs and their market introduction. Thanks to artificial intelligence, it is hoped that it will be possible to efficiently process the vast amounts of clinical data generated in studies or in the treatment of patients in hospitals. In this way, new interactions of substances and new therapeutic options are likely to be discovered. On the other hand, the company’s field staff should have data-driven analytical tools in their contacts with physicians and hospitals that allow them to present better therapeutic options for patients or better drug dosages.

Success is not guaranteed

The partnership between Novartis and Microsoft seems promising. Whether the potential can actually be realized is another question. It is recalled that in 2014 Basler and Internet company Google decided to develop and launch an “intelligent contact lens”. The plan was to use a lens and microchip lens that could be used for medical purposes such as diabetes treatment. The project was unsuccessful and ended at the end of 2018 sang- and soundless. The Google Novartis project is barely comparable to the Microsoft Novartis project, but shows that such cross-industry collaboration is not free of pitfalls.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

Can robots be more or less racist?

Protests against structural racism in the United States seem to have gone deep. Artificial intelligence (AI) developers have now...

American economist: US Economic future is bleak and the villain is the Fed

Many analysts link the recent record of the Wall Street Dow Jones index with optimism for a vaccine against COVID-19 and the transition of...

Scientists claim an unknown ability of alligators

The reptile's tail can reach up to 18% of its entire body length after losing its tail. American scientists have found that alligators can regenerate...

China condemns the blocking of its mobile apps in India

China opposes another ban on its mobile applications in India and calls on New Delhi to stop discriminating against Chinese companies on the grounds...

When the prey becomes a predator: a frog eats a snake

The viral video was captured by an Indian Forest Services officer where you can see a green frog eating a snake. Snakes in the animal's...
- Advertisement -

More Articles Like This

- Advertisement -